{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:30:39Z","timestamp":1771903839970,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T00:00:00Z","timestamp":1418688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychogeriatrics"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The use of cholinesterase inhibitors is recommended for the treatment of dementia with Lewy bodies (<jats:styled-content style=\"fixed-case\">DLB<\/jats:styled-content>) in the guidelines of the <jats:styled-content style=\"fixed-case\">DLB C<\/jats:styled-content>onsortium. However, no consensus regarding therapeutic approaches for <jats:styled-content style=\"fixed-case\">DLB<\/jats:styled-content>\u2010related visual hallucinations has been reached. To the best of our knowledge, an appropriate dose of donepezil for the treatment of <jats:styled-content style=\"fixed-case\">DLB<\/jats:styled-content> at each stage has not been discussed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eight patients suffering from <jats:styled-content style=\"fixed-case\">DLB<\/jats:styled-content> with visual hallucinations were treated with donepezil. We summarize the effects of donepezil on these visual hallucinations chronologically in all cases and discuss its efficacy and characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Donepezil contributed to the complete disappearance of visual hallucinations in all cases, and its effects were maintained for more than 6 months. However, relapses of visual hallucinations also occurred in all cases. Against these relapses, an increased dose of donepezil was very effective in resolving them again in almost all cases in this study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Donepezil was highly effective against visual hallucinations in <jats:styled-content style=\"fixed-case\">DLB<\/jats:styled-content> patients, but there were some issues regarding pharmacotherapy for <jats:styled-content style=\"fixed-case\">DLB<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/psyg.12089","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T13:56:16Z","timestamp":1418738176000},"page":"133-137","source":"Crossref","is-referenced-by-count":16,"title":["Long\u2010term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with <scp>L<\/scp>ewy bodies"],"prefix":"10.1111","volume":"15","author":[{"given":"Katsuyuki","family":"Ukai","sequence":"first","affiliation":[{"name":"Department of Psychogeriatrics Kamiiida Daiichi General Hospital  Nagoya Japan"},{"name":"Department of Psychiatry Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshige","family":"Fujishiro","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Iritani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685366"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00342237"},{"key":"e_1_2_6_4_1","first-page":"185","article-title":"Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease?","volume":"3","author":"Kosaka K","year":"1984","journal-title":"Clin Neuropathol"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.5.1113"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000187889.17253.b1"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91245-2"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000048636"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(200003)15:3<280::AID-GPS108>3.0.CO;2-N"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000351672"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8301.2008.00248.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(200004)15:4<338::AID-GPS119>3.0.CO;2-U"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03399-7"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2006.01485.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23557"},{"key":"e_1_2_6_16_1","first-page":"1165","article-title":"Efficacy of high\u2010dose donepezil in the treatment of neuropsychiatric symptoms in cases of dementia with Lewy bodies","volume":"51","author":"Manabe Y","year":"2009","journal-title":"Clinical Psychiatry"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10192"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8301.2010.00336.x"},{"key":"e_1_2_6_19_1","first-page":"56","article-title":"Efficacy of donepezil for the treatment of visual and multiple sensory hallucinations in dementia with Lewy bodies","volume":"2","author":"Ukai K","year":"2011","journal-title":"Clin Neuropharmacol Ther"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199403000-00002"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8301.2012.00413.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70194-0"}],"container-title":["Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpsyg.12089","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/psyg.12089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T19:47:32Z","timestamp":1696016852000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/psyg.12089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,16]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/psyg.12089"],"URL":"https:\/\/doi.org\/10.1111\/psyg.12089","archive":["Portico"],"relation":{},"ISSN":["1346-3500","1479-8301"],"issn-type":[{"value":"1346-3500","type":"print"},{"value":"1479-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,16]]}}}